Skip to content
NJ News HubNewsHub

Business

BeOne Medicines adds $300M Hopewell expansion, bringing investment above $1B

Source: ROI-NJ · Jul 23, 2026, 10:00 AM

AI-assisted briefing from the publisher’s public headline and excerpt — not original reporting. How we write briefings

BeOne Medicines Hopewell facility expansion at Princeton West Innovation Campus

BeOne Medicines, a Switzerland-based oncology company operating in New Jersey, announced a $300 million expansion of its manufacturing and research facility at Princeton West Innovation Campus in Hopewell.

This major investment brings the company's total U.S. manufacturing commitment to over $1 billion, reflecting significant growth in the state's life sciences sector.

Key points

  • BeOne Medicines announced $300M expansion at Hopewell facility
  • Total U.S. manufacturing investment now exceeds $1 billion
  • Expansion includes clinical and commercial-stage manufacturing and R&D operations
  • Location is Princeton West Innovation Campus in Hopewell, New Jersey
  • Switzerland-domiciled oncology company strengthening New Jersey operations

FAQ

What is BeOne Medicines expanding in New Jersey?
BeOne Medicines is expanding its flagship clinical and commercial-stage manufacturing and research and development center at Princeton West Innovation Campus in Hopewell, New Jersey with a $300 million investment.
How much total has BeOne Medicines invested in U.S. manufacturing?
BeOne Medicines' total U.S. manufacturing investment now exceeds $1 billion, with the recent $300 million expansion contributing significantly to this figure.
Where is the expansion located?
The expansion is located at the Princeton West Innovation Campus in Hopewell, New Jersey.

Briefing prepared for NJ News Hub. Verify details on the original story. See our editorial policy.

Related